Reversible HER2 antibody-drug conjugate-induced ocular toxicity.
Sharma A, Riaz KM, Gill MS, Patnaik A, Ulahannan SV, Wang JS, Gombos DS, Ang Q, Cicic D, Bergonio GR, Zhang C, Wirostko BM.
Sharma A, et al. Among authors: cicic d.
Can J Ophthalmol. 2022 Apr;57(2):118-126. doi: 10.1016/j.jcjo.2021.02.028. Epub 2021 Mar 13.
Can J Ophthalmol. 2022.
PMID: 33727105